Eiger BioPharmaceuticals
Utility Patents
Last updated:
List of all Eiger BioPharmaceuticals patents 8 in total
| Status | Patent |
|---|---|
Grant | Utility: Treatment of hepatitis delta virus infection Filling date: 6 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Buffered formulations of exendin (9-39) Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Treatment of hepatitis delta virus infection with interferon lambda Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Pharmaceutical compositions comprising lonafarnib and ritonavir Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Treatment of hepatitis delta virus infection Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Showing 1 to 8 of 8 patents.